Key Market Indicators
Estonian beta blocking medicine sales are projected to reach $7.54 million by 2026. This figure marks an increase of 1.1% annually since 2021, where it was recorded at $7.26 million. Since 2004, the market has grown by a yearly average of 3.9%. In 2021, Estonia ranked 22nd for sales, with Latvia coming in higher at $7.26 million. Italy, Canada and Australia followed, coming in at second, third and fourth respectively.
